Trials / Completed
CompletedNCT03491917
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer
A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Fujifilm Medical Systems USA, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this pilot is to provide credible performance estimate information in order to conduct a subsequent pivotal reader study.
Detailed description
This clinical research is a retrospective, pilot, multi-reader, multi-case (MRMC) study with an enriched sample of 100 breast screening or diagnostic cases which were selected from the library of mammograms collected under Fujifilm protocol FMSU2013-004A (all subjects previously provided written informed consent agreeing their image data and supporting documentation could be used for future research and investigations). Approximately 6 qualified radiologists will independently perform two reads on all (approximately 100) cases. Each reader will read each case both as a FFDM (Full Field Digital Mammography) read, and a DBT (Digital Breast Tomosynthesis) plus S-View (Synthesized View) read on the ASPIRE Bellus II workstation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DBT plus S-View | DBT plus S-View images |
| DEVICE | FFDM alone | FFDM alone images |
Timeline
- Start date
- 2017-11-03
- Primary completion
- 2017-12-31
- Completion
- 2018-02-15
- First posted
- 2018-04-09
- Last updated
- 2020-06-18
- Results posted
- 2020-06-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03491917. Inclusion in this directory is not an endorsement.